Bictegravir/Lenacapavir: A 2-Drug Regimen for the Treatment of HIV-1 Infection.

Chahine EB, Faragon JJ, Patel N, Sherman EM

DOI: 10.1177/10600280261496876
Published: 2026 Oct 29
Container: The Annals of pharmacotherapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/10600280261496876,
  title = {Bictegravir/Lenacapavir: A 2-Drug Regimen for the Treatment of HIV-1 Infection.},
  author = {Chahine EB and Faragon JJ and Patel N and Sherman EM},
  year = {2026},
  journal = {The Annals of pharmacotherapy},
  doi = {10.1177/10600280261496876},
  url = {https://doi.org/10.1177/10600280261496876}
}

RIS

TY  - JOUR
TI  - Bictegravir/Lenacapavir: A 2-Drug Regimen for the Treatment of HIV-1 Infection.
AU  - Chahine EB
AU  - Faragon JJ
AU  - Patel N
AU  - Sherman EM
PY  - 2026
JO  - The Annals of pharmacotherapy
DO  - 10.1177/10600280261496876
UR  - https://doi.org/10.1177/10600280261496876
ER  -

APA

EB, C., JJ, F., N, P., & EM, S. (2026). Bictegravir/Lenacapavir: A 2-Drug Regimen for the Treatment of HIV-1 Infection.. The Annals of pharmacotherapy. https://doi.org/10.1177/10600280261496876

Source records

pubmed · retrieved 2026-11-10T20:14:21.941Z